Cilostazol 100 mg (5411)
Cilostazol
Product Images NDC 54868-5411
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 54868-5411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Cilostazol Tablets Usp 1)
Graph (Cilostazol Tablets Usp 2)
This appears to be a pharmacology chart displaying the plasma concentration of three drugs (Cilostazol, 3,4-dehydro-cilostazol, and 4-trans-hydroxy-cilostazol) over time (in hours) in ng/mL. It is not possible to determine the full context or purpose of the chart without additional information.*
Graph 2 (Cilostazol Tablets Usp 3)
Percent Mean improvement in Maximal Walking Distance for eight randomized, double-blind, placebo-controlled clinical trials of Cilostazol with varying doses and study durations. The percentage ranged from 20 to 100, with two doses mentioned; Cilostazol 50mg bid and Cilostazol 100mg b..d. However, the text is of poor quality, and some characters are not readable, making it difficult to provide a precise description.*
Logo (Cilostazol Tablets Usp 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
